HGF/c-Met signaling mediated mesenchymal stem cell-induced liver recovery in intestinal ischemia reperfusion model

International Journal of Medical Sciences

Volumn 11, Issue 6, 2014, Pages 626-633

  Liu, Jianpei ^a   Pan, Guozheng ^b   Liang, Tangzhao ^a   Huang, Pinjie ^c  

^a Department of Gastrointestinal Surgery ^*  (China)

^b Liver Transplantation Center   (China)

^c THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Hepatocyte growth factor; Intestine; Ischemia reperfusion; Liver injury; Mesenchymal stem cell

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; SCATTER FACTOR RECEPTOR; HGF ACTIVATOR; INDUCIBLE NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, HUMAN; SERINE PROTEINASE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL HOMING; CELL MIGRATION; CONTROLLED STUDY; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; INTESTINE ISCHEMIA; LIVER INJURY; LIVER PROTECTION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; ANIMAL; CELL PROLIFERATION; GENETICS; HUMAN; INJURIES; LIVER; LIVER CELL; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY;

ANIMALS; CELL PROLIFERATION; HEPATOCYTES; HUMANS; LIVER; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; NITRIC OXIDE SYNTHASE TYPE II; RATS; REPERFUSION INJURY; SERINE ENDOPEPTIDASES; SIGNAL TRANSDUCTION;

EID: 84899628036     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.8228     Document Type: Article

References (43)

1. Haglund U, Bergqvist D. Intestinal ischemia -the basics. Langenbecks Arch Surg. 1999; 384: 233-38.
2. Mallick IH, Yang W, Winslet MC, et al. Ischemia-reperfusion injury of the intestine and protective strategies against injury. Dig Dis Sci. 2004; 49: 1359-77.
3. Harward TR, Brooks DL, Flynn TC, et al. Multiple organ dysfunction after mesenteric artery revascularization. J Vasc Surg. 1993; 18: 459/467, 467-69.
4. Oldenburg WA, Lau LL, Rodenberg TJ, et al. Acute mesenteric ischemia: a clinical review. Arch Intern Med. 2004; 164: 1054-62.
5. Turnage RH, Bagnasco J, Berger J, et al. Hepatocellular oxidant stress following intestinal ischemia-reperfusion injury. J Surg Res. 1991; 51: 467-471.
6. Yao JH, Li YH, Wang ZZ, et al. Proteasome inhibitor lactacystin ablates liver injury induced by intestinal ischaemia-reperfusion. Clin Exp Pharmacol Physiol. 2007; 34: 1102-08.
7. Tomita M, Kishimoto H, Takizawa Y, et al. Effects of intestinal ischemia/reperfusion on P-glycoprotein mediated biliary and renal excretion of rhodamine123 in rat. Drug Metab Pharmacokinet. 2009; 24: 428-37.
8. Naito Y, Takagi T, Ichikawa H, et al. A novel potent inhibitor of inducible nitric oxide inhibitor, ONO-1714, reduces intestinal ischemia-reperfusion injury in rats. Nitric Oxide. 2004; 10: 170-77.
9. Friedenstein AJ, Chailakhyan RK, Latsinik NV, et al. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation. 1974; 17: 331-40.
10. Brooke G, Cook M, Blair C, et al. Therapeutic applications of mesenchymal stromal cells. Semin Cell Dev Biol. 2007; 18: 846-58.
11. Mias C, Trouche E, Seguelas MH, et al. Ex vivo pretreatment with melatonin improves survival, proangiogenic/mitogenic activity, and efficiency of mesenchymal stem cells injected into ischemic kidney. Stem Cells. 2008; 26: 1749-57.
12. Togel F, Weiss K, Yang Y, et al. Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am J Physiol Renal Physiol. 2007; 292: F1626-35.
13. Cheng Z, Ou L, Zhou X, et al. Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance. Mol Ther. 2008; 16: 571-79.
14. Sasaki M, Abe R, Fujita Y, et al. Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J Immunol. 2008; 180: 2581-87.
15. Oyagi S, Hirose M, Kojima M, et al. Therapeutic effect of transplanting HGF-treated bone marrow mesenchymal cells into CCl4-injured rats. J Hepatol. 2006; 44: 742-48.
16. Zhao J, Zhang N, Prestwich GD, et al. Recruitment of endogenous stem cells for tissue repair. Macromol Biosci. 2008; 8: 836-42.
17. Michalopoulos GK, DeFrances MC. Liver regeneration. Science. 1997; 276: 60-66.
18. Zhang YW, Vande WG. HGF/SF-met signaling in the control of branching morphogenesis and invasion. J Cell Biochem. 2003; 88: 408-17.
19. Birchmeier C, Gherardi E. Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol. 1998; 8: 404-10.
20. Huh CG, Factor VM, Sanchez A, et al. Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair. Proc Natl Acad Sci U S A. 2004; 101: 4477-82.
21. Valdes-Arzate A, Luna A, Bucio L, et al. Hepatocyte growth factor protects hepatocytes against oxidative injury induced by ethanol metabolism. Free Radic Biol Med. 2009; 47: 424-30.
22. Phaneuf D, Chen SJ, Wilson JM. Intravenous injection of an adenovirus encoding hepatocyte growth factor results in liver growth and has a protective effect against apoptosis. Mol Med. 2000; 6: 96-103.
23. Pan GZ, Yang Y, Zhang J, et al. Bone marrow mesenchymal stem cells ameliorate hepatic ischemia/reperfusion injuries via inactivation of the MEK/ERK signaling pathway in rats. J Surg Res. 2012; 178: 935-48.
24. Pierro A, Eaton S. Intestinal ischemia reperfusion injury and multisystem organ failure. Semin Pediatr Surg. 2004; 13: 11-17.
25. Sheng ZY, Dong YL, Wang XH. Bacterial translocation and multiple system organ failure in bowel ischemia and reperfusion. Chin Med J (Engl). 1991; 104: 897-903.
26. Olanders K, Sun Z, Borjesson A, et al. The effect of intestinal ischemia and reperfusion injury on ICAM-1 expression, endothelial barrier function, neutrophil tissue influx, and protease inhibitor levels in rats. Shock. 2002; 18: 86-92.
27. Yao JH, Zhang XS, Zheng SS, et al. Prophylaxis with carnosol attenuates liver injury induced by intestinal ischemia/reperfusion. World J Gastroenterol. 2009; 15: 3240-45.
28. Jung YJ, Ryu KH, Cho KA, et al. In vitro hepatic differentiation of human umbilical cord blood and bone marrow cells. Pediatr Hematol Oncol. 2008; 25: 481-91.
29. Cho KA, Woo SY, Seoh JY, et al. Mesenchymal stem cells restore CCl4-induced liver injury by an antioxidative process. Cell Biol Int. 2012; 36: 1267-74.
30. Chen Y, Shao JZ, Xiang LX, et al. Mesenchymal stem cells: a promising candidate in regenerative medicine. Int J Biochem Cell Biol. 2008; 40: 815-20.
31. Sackstein R, Merzaban JS, Cain DW, et al. Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone. Nat Med. 2008; 14: 181-87.
32. Wojakowski W, Kucia M, Kazmierski M, et al. Circulating progenitor cells in stable coronary heart disease and acute coronary syndromes: relevant reparatory mechanism? Heart. 2008; 94: 27-33.
33. Swenson ES, Guest I, Ilic Z, et al. Hepatocyte nuclear factor-1 as marker of epithelial phenotype reveals marrow-derived hepatocytes, but not duct cells, after liver injury in mice. Stem Cells. 2008; 26: 1768-77.
34. Tsai PC, Fu TW, Chen YM, et al. The therapeutic potential of human umbilical mesenchymal stem cells from Wharton's jelly in the treatment of rat liver fibrosis. Liver Transpl. 2009; 15: 484-95.
35. van Poll D, Parekkadan B, Cho CH, et al. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology. 2008; 47: 1634-43.
36. Sgodda M, Aurich H, Kleist S, et al. Hepatocyte differentiation of mesenchymal stem cells from rat peritoneal adipose tissue in vitro and in vivo. Exp Cell Res. 2007; 313: 2875-86.
37. Togel F, Hu Z, Weiss K, et al. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol. 2005; 289: F31-42.
38. Markel TA, Wang Y, Herrmann JL, et al. VEGF is critical for stem cell-mediated cardioprotection and a crucial paracrine factor for defining the age threshold in adult and neonatal stem cell function. Am J Physiol Heart Circ Physiol. 2008; 295: H2308-14.
39. Wang Y, Hu F, Wang ZJ, et al. Administration of bone marrow-derived stem cells suppresses cellular necrosis and apoptosis induced by reperfusion of ischaemic kidneys in rats. Chin Med J (Engl). 2008; 121: 268-71.
40. Rehman J, Traktuev D, Li J, et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation. 2004; 109: 1292-98.
41. Morigi M, Introna M, Imberti B, et al. Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice. Stem Cells. 2008; 26: 2075-82.
42. Higashiyama R, Inagaki Y, Hong YY, et al. Bone marrow-derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice. Hepatology. 2007; 45: 213-22.
43. Kallis YN, Alison MR, Forbes SJ. Bone marrow stem cells and liver disease. Gut. 2007; 56: 716-24.